These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone. Burns ER; Scheving LE Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892 [No Abstract] [Full Text] [Related]
9. [DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]. Morishima Y; Yamada K; Kawashima K; Ohno R; Ezaki K; Kodera Y; Kobayashi M; Takeyama H; Kato Y; Watanabe E; Suzuki H; Yamaguchi H; Tanimoto M; Minami S; Yokomaku S; Ogura M; Morishita T; Nishiwaki H; Yamada H; Ohara K; Yoshikawa S Rinsho Ketsueki; 1980 Jan; 21(1):33-8. PubMed ID: 7373867 [No Abstract] [Full Text] [Related]
10. Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia. Wiernik PH Cancer Treat Rep; 1981; 65 Suppl 4():67-71. PubMed ID: 7049382 [No Abstract] [Full Text] [Related]
11. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study. Miller LP; Miller DR; Tan CT Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604 [No Abstract] [Full Text] [Related]
12. [Acute leukemia results of treatment at a provincial hospital]. Magnusson S; Möller BH Lakartidningen; 1980 Oct; 77(40):3516-7. PubMed ID: 7453351 [No Abstract] [Full Text] [Related]
13. [Leukemia in children in the Netherlands]. de Vries JA Tijdschr Kindergeneeskd; 1982 Dec; 50(6):177-81. PubMed ID: 6963035 [TBL] [Abstract][Full Text] [Related]
14. High remission induction (traditional sino-western HOAP) regimen for acute nonlymphocytic leukemia. Chin Med J (Engl); 1980 Aug; 93(8):565-8. PubMed ID: 6772409 [No Abstract] [Full Text] [Related]
16. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study. Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637 [TBL] [Abstract][Full Text] [Related]
17. Some pharmacologic considerations concerning the control of acute leukemia. Nichol CA Cancer Res; 1965 Oct; 25(9):1532-40. PubMed ID: 5323966 [No Abstract] [Full Text] [Related]
18. [Intestinal and skin microflora changes in acute leukemia patients during decontamination]. Nasonova TA; Mal'tsev VN; Smirnova OV; Isichenko IB; Reshchikova EV Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):24-8. PubMed ID: 7279891 [No Abstract] [Full Text] [Related]
19. Management of leukaemia in a developing country (Kenya). Kasili EG East Afr Med J; 1978 Sep; 55(9):417-9. PubMed ID: 710347 [No Abstract] [Full Text] [Related]